Phase 1 Dose-escalating Study of MM-398 (Irinotecan Sucrosofate Liposome Injection) Plus Intravenous Cyclophosphamide in Recurrent or Refractory Pediatric Solid Tumors

Clinical trial NCT02013336 · UNKNOWN

Trial details

NCT number: NCT02013336
Sponsor: South Plains Oncology Consortium
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent or Refractory Solid Tumors Ewing Sarcoma Rhabdomyosarcoma Neuroblastoma Osteosarcoma

Start date: 2013-12-01
Primary completion: 2023-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.